ELI LILLY & Co — Director's Dealing 2020

Jan 9, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2020-01-01

Reporting Person: Mason Michael B (Sr. VP & Pres., Lilly Diabetes)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	9250	Direct
Common Stock	865	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock Unit	$	2020-09-01	Common Stock (6244.0)		Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.